Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1995-10-3
|
pubmed:abstractText |
Objectives of our work were to determine whether the presence of endometriosis, stage and the activity of the disease influence the sperm-peritoneal fluid (PF) incubation test and, possibly, whether a GnRH agonist (GnRHa) treatment in these patients can reduce the PF toxicity toward sperms. Preovulatory PFs from 18 patients with endometriosis (11 stage I-II rAFS and/stage III-IV; 10 with active lesions and 8 with inactive disease), and from 15 women with unexplained infertility were collected and frozen at the time of diagnostic laparoscopy. The ten patients with active endometriosis were treated by 3 months ovarian desensitization by a GnRH a (Decapeptyl 3.75 mg, Ipsen, Milan Italy) followed by a controlled ovarian hyperstimulation with a purified FSH (Metrodin, Serono, Rome, Italy) and HCG 10.000 UI (Profasi, Serono) when appropriate. In these patients, immediately before performing intrauterine and/or intraperitoneal insemination, a small aliquot of PF was collected transvaginally checking the absence of oocytes. Five hundreds suspension for one hour. PFs inducing a decrease in sperm motility greater than 20% were defined "toxic". The prevalence of toxic PF was not statistically greater in endometriosis (8/18) than in unexplained infertility (3/15) and was not dependent upon the stage of the disease, while it was significantly (rho = 0.01) more frequent in patients with active endometriosis (7/10) than other women (4/23). After a three months GnRHa treatment of these patients the rate of toxic PFs was significantly (p = 0.02) decreased (1 out of 10 treated cases).(ABSTRACT TRUNCATED AT 250 WORDS)
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0587-2421
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
291-3
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:7660716-Ascitic Fluid,
pubmed-meshheading:7660716-Endometriosis,
pubmed-meshheading:7660716-Female,
pubmed-meshheading:7660716-Follicle Stimulating Hormone,
pubmed-meshheading:7660716-Gonadotropin-Releasing Hormone,
pubmed-meshheading:7660716-Humans,
pubmed-meshheading:7660716-Infertility, Female,
pubmed-meshheading:7660716-Male,
pubmed-meshheading:7660716-Ovulation Induction,
pubmed-meshheading:7660716-Prevalence,
pubmed-meshheading:7660716-Reproductive Techniques,
pubmed-meshheading:7660716-Severity of Illness Index,
pubmed-meshheading:7660716-Sperm Motility,
pubmed-meshheading:7660716-Spermatozoa,
pubmed-meshheading:7660716-Triptorelin Pamoate
|
pubmed:articleTitle |
Sperm-peritoneal fluid incubation test: influence of a GnRH agonist treatment.
|
pubmed:affiliation |
Dept of Gynecological and Pediatric Sciences, Catanzaro, School of Medicine, Italy.
|
pubmed:publicationType |
Journal Article
|